William E. Klunk
19Patents
7h-index
3Co-inventors
59Inventor score
Filing activity: Apr 18, 1997 → Oct 5, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6417178B1 | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits | Physics | 87 | Expired |
| US6168776A | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 68 | Expired |
| US6114175A | Compound for the antemortem diagnosis of Alzheimer's Disease and in vivo imaging and prevention of amyloid deposition | Physics | 33 | Expired |
| US7270800B2 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 23 | Expired |
| US6133259A | Alkyl, alkenyl and alkynyl chrysamine G derivatives for inhibition of cell degeneration and toxicity associated with amyloid deposition | Physics | 15 | Expired |
| US7351401B2 | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition | Chemistry; Metallurgy | 11 | Expired |
| US7854920B2 | Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 8 | Active |
| US8147798B2 | Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies | Human Necessities | 7 | Active |
| US8404213B2 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 6 | Active |
| US8236282B2 | Benzothiazole derivative compounds, compositions and uses | Physics | 6 | Active |
| US8343457B2 | Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies | Human Necessities | 4 | Active |
| US8580229B2 | Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies | Human Necessities | 4 | Active |
| US8138360B2 | Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins | Human Necessities | 4 | Active |
| US8691185B2 | Benzothiazole derivative compounds, compositions and uses | Physics | 4 | Active |
| US9134328B2 | Methods of using benzothiazole derivative compounds and compositions | Physics | 3 | Active |
| US8911707B2 | Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 3 | Active |
| US9808541B2 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 1 | Active |
| US9833458B2 | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Chemistry; Metallurgy | 0 | Active |
| US10137210B2 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.